Arab Journal of Gastroenterology
Volume 11, Issue 3 , Pages 136-140 , September 2010

Interstitial pulmonary changes in patients with hepatitis C-related chronic liver disease

Received 16 March 2010 ,Accepted 3 July 2010.

References 

  1. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis. 1995;15(1):5–14
  2. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997;26(3 Suppl 1):15S–20S
  3. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 1993;82(12):3701–3704
  4. Pawlotsky JM, Roudot Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med. 1995;122(3):169–173
  5. Agnello V. Mixed cryoglobulinemia and other extrahepatic manifestations of HCV infection. In:  Liang TJ,  Hoofnagle JH editor. Hepatitis C. New York: Academic Press; 2000;p. 295–315
  6. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’étude et de recherche en médecine interne et maladies infectieuses sur le virus de l’hépatite C. Medicine (Baltimore). 2000;79(1):47–56
  7. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC group. Multidepartment virus C. Arthritis Rheum. 1999;42(10):2204–2212
  8. Galossi A, Guarisco R, Bellis L, et al. Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis. 2007;16(1):65–73
  9. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277–304. Erratum in: Am J Respir Crit Care Med 2002;166:426.
  10. Kula M, Gulmez I, Tutus A, et al. Impaired lung epithelial permeability in hepatitis C virus antibody positive patients detected by 99mTc-DTPA aerosol scintigraphy. Nucl Med Commun. 2002;23(5):441–446
  11. Yamaguchi S, Kubo K, Fujimoto K, et al. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax. 1997;52(1):33–37
  12. Ueda T, Ohta K, Suzuki N, et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis. 1992;146(1):266–268
  13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117
  14. Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90(1):42–53
  15. Javaheri S, Sicilian L. Lung function, breathing pattern and gas exchange in interstitial lung disease. Thorax. 1992;47(2):93–97
  16. Goldman HI, Beclake M. Respiratory function tests: normal values at medium altitudes and the prediction of normal results. Am Rev Tuberc. 1959;79:454–467
  17. Paoletti P, Pistelli G, Fazzi P, et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir. 1986;22(5):451–459
  18. Cotes JE, Dabbs JM, Hall AM, et al. Lung volumes, ventilatory capacity and transfer factor in healthy British boy and girl twins. Thorax. 1973;28(6):709–715
  19. Remy Jardin M, Giraud F, Remy J, et al. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology. 1994;191(3):675–680
  20. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis. 1993;148(6 Pt 1):1683–1684
  21. Ferri C, La Civita L, Fazzi P, et al. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol. 1997;36(3):360–365
  22. Arase Y, Suzuki F, Suzuki Y, et al. Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol. 2008;14(38):5880–5886
  23. Terrault NA, Wright TL. Viral hepatitis A through G. In:  Feldman M,  Sleisinger MH,  Scharschmidt BF editor. Gastrointestinal and liver disease. 6th ed.. W.B. Saunders; 1998;p. 1123–1170
  24. Kanengiser LC, Rapoport DM, Epstein H, et al. Volume adjustment of mechanics and diffusion in interstitial lung disease. Lack of clinical relevance. Chest. 1989;96(5):1036–1042
  25. Crapo RO, Forster RE. Carbon monoxide diffusing capacity. Clin Chest Med. 1989;10(2):187–198
  26. Fenlon HM, Doran M, Sant SM, et al. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol. 1996;166(2):301–307

PII: S1687-1979(10)00084-5

doi: 10.1016/j.ajg.2010.07.002

Arab Journal of Gastroenterology
Volume 11, Issue 3 , Pages 136-140 , September 2010

Article Tools